Chairman Sanders Launches Investigation Into Outrageously High Price of Ozempic and Wegovy in the United States
April 25, 2024
April 25, 2024
WASHINGTON, April 25 -- Sen. Bernie Sanders, I-Vermont, issued the following news release on April 24, 2024:
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today sent a letter to the CEO of Novo Nordisk, launching an investigation into the outrageously high prices his pharmaceutical company is charging for Ozempic and Wegovy in the United States.
In his letter, Chairman Sanders wrote, "The scientists at . . .
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today sent a letter to the CEO of Novo Nordisk, launching an investigation into the outrageously high prices his pharmaceutical company is charging for Ozempic and Wegovy in the United States.
In his letter, Chairman Sanders wrote, "The scientists at . . .